Coverage
-
July 08, 2026
Microbiome treatment developer Finch Therapeutics will ask a Delaware bankruptcy judge to approve a Chapter 11 plan that would allow it to sell all assets to a rival company and exit bankruptcy. Here's a look at the liquidating plan it is hoping to get confirmed.
4 other articles on this case.
View all »